Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abeona Therapeutics
(NQ:
ABEO
)
5.515
+0.395 (+7.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abeona Therapeutics
< Previous
1
2
3
4
5
Next >
Abeona Therapeutics Announces Regulatory Update on Biologics License Application (BLA) for EB-101
June 09, 2023
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics to Present at the Jefferies Healthcare Conference
June 01, 2023
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics Announces Date Change for First Quarter 2023 Portfolio Update Conference Call to May 24, 2023
May 22, 2023
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Recap: Abeona Therapeutics Q1 Earnings
May 11, 2023
Via
Benzinga
Cantor Bullish On Abeona Saying Recent Trial Data 'Best Case Scenario'
November 08, 2022
Via
Benzinga
Abeona Therapeutics Touts Positive Data From Pivotal EB-101 Study In Blistering Skin Disorder
November 03, 2022
Via
Benzinga
Recap: Abeona Therapeutics Q2 Earnings
August 11, 2022
Abeona Therapeutics (NASDAQ:ABEO) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Abeona Therapeutics Announces New Preclinical Data from its AAV Ophthalmology Program at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
May 16, 2023
Animal proof-of-concept for AAV-based gene therapies for Stargardt disease, X-linked retinoschisis and autosomal dominant optic atrophy
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics Reports First Quarter 2023 Financial Results
May 11, 2023
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics Announces Additional Phase 3 VIITAL™ Study Results for EB-101 Presented at the International Societies for Investigative Dermatology 2023 Meeting
May 11, 2023
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics Announces Multiple Abstracts Accepted from its AAV Ophthalmology Program at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
April 10, 2023
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
March 29, 2023
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics Announces New Employee Inducement Grants
March 24, 2023
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics Announces Acceptance of Abstract on EB-101 Phase 3 VIITAL™ Study Results for Oral Presentation at International Societies for Investigative Dermatology (ISID) 2023 Meeting
March 16, 2023
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics Announces Update on AAV Ophthalmology Program
March 14, 2023
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Three Small-Cap Biotech Stocks to Consider Now
December 12, 2022
This article looks at three small-cap biotech companies with stock prices that are making significant moves and have a bright outlook for 2023
Via
MarketBeat
PXMD, GETY: The Top 5 Short Squeeze Stocks to Watch This Week
November 21, 2022
We're checking in on the top short squeeze stocks to watch this week as traders continue to have an interest in this part of the market!
Via
InvestorPlace
PaxMedica, Getty Images And 3 Short Squeeze Candidates That Could Soar This Week
November 21, 2022
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move.
Via
Benzinga
Abeona Therapeutics Reports Third Quarter 2022 Financial Results
November 14, 2022
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics Announces $35 Million Private Placement Financing
November 03, 2022
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics Announces Positive Topline Results with Both Co-Primary Endpoints Met in Pivotal Phase 3 VIITAL™ Study of EB-101
November 03, 2022
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics Announces Database Lock for Pivotal Phase 3 VIITAL™ Study of EB-101 in Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)
October 19, 2022
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
How Is The Market Feeling About Abeona Therapeutics?
October 07, 2022
Abeona Therapeutics's (NASDAQ:ABEO) short percent of float has fallen 9.04% since its last report. The company recently reported that it has 177 thousand shares sold short, which is 3.02% of all...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 07, 2022
Gainers Inventiva (NASDAQ:IVA) shares increased by 44.0% to $5.88 during Friday's regular session. The market value of their outstanding shares is at $247.6 million.
Via
Benzinga
Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday
October 17, 2022
Gainers Agrify Corporation (NASDAQ: AGFY) climbed 53.8% to close at $1.45. FedNat Holding Company (NASDAQ: FNHC) gained 48% to settle at $0.52.
Via
Benzinga
Abeona Therapeutics Announces Completion of Patient Follow-up in Pivotal Phase 3 VIITAL™ Study of EB-101 in Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)
October 04, 2022
Topline VIITAL™ study results expected within the next month
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday
October 10, 2022
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 04, 2022
Via
Benzinga
Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday's Mid-Day Session
October 07, 2022
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday.
Via
Benzinga
Tesla, Twitter And 76 Biggest Movers From Friday
July 11, 2022
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.